We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MGRX market cap is 4.6M. The company's latest EPS is USD -0.5406 and P/E is -0.50.
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Revenue | 9k | 101k | 141k | 245k | 244k |
Operating Income | -672k | -2.56M | -2.29M | -1.8M | -2.57M |
Net Income | -674k | -2.56M | -2.28M | -1.8M | -2.57M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 9k | 731k |
Operating Income | -18k | -1.99M | -9.22M |
Net Income | -18k | -2M | -9.21M |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Total Assets | 1M | 4.12M | 3.3M | 1.6M | 1.05M |
Total Liabilities | 389k | 296k | 294k | 241k | 276k |
Total Equity | 614k | 3.82M | 3M | 1.36M | 775k |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 23k | 1M | 1.05M |
Total Liabilities | 40k | 389k | 276k |
Total Equity | -17k | 614k | 775k |
Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |||
Operating | -1.35M | -1.81M | -3.59M | -5.3M | -7M |
Investing | -43k | -4k | -4k | -4k | -4k |
Financing | 2.05M | 4.92M | 5.86M | 5.86M | 7.06M |
Year End 31 December 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | |
Operating | -18k | -1.35M | -7M |
Investing | N/A | -43k | -4k |
Financing | 41k | 2.05M | 7.06M |
Market Cap | 4.6M |
Price to Earnings Ratio | -0.50 |
Price to Sales Ratio | 6.29 |
Price to Cash Ratio | 6.22 |
Price to Book Ratio | 5.94 |
Dividend Yield | - |
Shares Outstanding | 17.04M |
Average Volume (1 week) | 62.91k |
Average Volume (1 Month) | 132.63k |
52 Week Change | -77.31% |
52 Week High | 2.38 |
52 Week Low | 0.143 |
Spread (Intraday) | 0.01 (3.81%) |
Company Name | Mangoceuticals Inc |
Address |
15110 n. dallas parkway, suite 600 dallas, texas 75248 |
Website | https://www.mangorx.com |
Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions